Fuller & Thaler Asset Management
AMED

Fuller & Thaler Asset Management’s Amedisys AMED Stock Holding History

Fuller & Thaler Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16
Closed -$1.54K – 607
2024
Q3 		$1.54K Hold
16
– – ﹤0.01% 550
2024
Q2 		$1.47K Hold
16
– – ﹤0.01% 544
2024
Q1 		$1.48K Hold
16
– – ﹤0.01% 531
2023
Q4 		$1.52K Buy
16
+2
+14% +$187 ﹤0.01% 512
2023
Q3 		$1.31K Hold
14
– – ﹤0.01% 509
2023
Q2 		$1.28K Hold
14
– – ﹤0.01% 499
2023
Q1 		$1.03K Hold
14
– – ﹤0.01% 510
2022
Q4 		$1K Sell
14
-99,470
-100% -$8.97M ﹤0.01% 506
2022
Q3 		$9.63M Buy
99,484
+130
+0.1% +$15.5K 0.07% 205
2022
Q2 		$10.4M Sell
99,354
-536
-0.5% -$68.5K 0.07% 206
2022
Q1 		$17.2M Buy
99,890
+516
+0.5% +$77.1K 0.1% 180
2021
Q4 		$16.1M Sell
99,374
-384
-0.4% -$61.7K 0.09% 184
2021
Q3 		$14.9M Sell
99,758
-122,355
-55% -$25.4M 0.1% 183
2021
Q2 		$54.4M Buy
222,113
+53,813
+32% +$14.1M 0.35% 96
2021
Q1 		$44.6M Sell
168,300
-38,531
-19% -$10.9M 0.31% 104
2020
Q4 		$60.7M Buy
206,831
+1,767
+0.9% +$453K 0.56% 62
2020
Q3 		$48.5M Sell
205,064
-75,497
-27% -$17.2M 0.61% 57
2020
Q2 		$55.7M Buy
280,561
+36,946
+15% +$6.89M 0.73% 46
2020
Q1 		$44.7M Buy
243,615
+26,394
+12% +$4.7M 0.75% 43
2019
Q4 		$36.3M Sell
217,221
-236
-0.1% -$35.1K 0.4% 88
2019
Q3 		$28.5M Sell
217,457
-50,130
-19% -$6.53M 0.34% 97
2019
Q2 		$32.5M Sell
267,587
-28,408
-10% -$3.37M 0.38% 91
2019
Q1 		$36.5M Buy
295,995
+33,522
+13% +$4.21M 0.46% 78
2018
Q4 		$30.7M Buy
262,473
+25,013
+11% +$2.95M 0.44% 76
2018
Q3 		$29.7M Buy
+237,460
New +$26.2M 0.31% 100
2016
Q4 		– Sell
-600
Closed -$28K – 719
2016
Q3 		$28K Hold
600
– – ﹤0.01% 686
2016
Q2 		$30K Buy
+600
New +$30.3K ﹤0.01% 661
2015
Q1 		– Sell
-303,520
Closed -$8.91M – 647
2014
Q4 		$8.91M Buy
+303,520
New +$7.49M 0.32% 81

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Fuller & Thaler Asset Management's AMED Position: Q4 2024 in Review

Fuller & Thaler Asset Management sold out of Amedisys (AMED) in Q4 2024, closing a stake of 16 shares — an estimated $1.54K sold.

Fuller & Thaler Asset Management first reported a position in AMED in Q4 2014 and held it in 28 quarters. The position peaked at $60.7M in Q4 2020. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Fuller & Thaler Asset Management reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 16 Amedisys shares in Q4 2024, an estimated $1.54K.
  • Fuller & Thaler Asset Management first reported a position in Amedisys in Q4 2014 and held it in 28 quarters.
  • Fuller & Thaler Asset Management's Amedisys position peaked at $60.7M in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.